Latest Insider Transactions at Steris PLC (STE)
This section provides a real-time view of insider transactions for Steris PLC (STE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STERIS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STERIS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
1,682
-12.88%
|
$364,994
$217.32 P/Share
|
|
Oct 01
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-1.13%
|
$18,330
$235.78 P/Share
|
|
Oct 01
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.45%
|
$45,590
$235.78 P/Share
|
|
Oct 01
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.27%
|
$21,385
$235.78 P/Share
|
|
Oct 01
2024
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-0.59%
|
$6,110
$235.78 P/Share
|
|
Oct 01
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.23%
|
$30,550
$235.78 P/Share
|
|
Oct 01
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-2.59%
|
$58,750
$235.78 P/Share
|
|
Sep 16
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
20,213
-9.01%
|
$4,952,185
$245.24 P/Share
|
|
Sep 16
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,213
+24.25%
|
$2,304,282
$114.22 P/Share
|
|
Sep 13
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
3,119
-6.77%
|
$773,512
$248.02 P/Share
|
|
Sep 13
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,119
+6.34%
|
$355,566
$114.22 P/Share
|
|
Sep 10
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
23,332
-35.21%
|
$5,763,004
$247.0 P/Share
|
|
Sep 10
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
23,332
+26.04%
|
$2,659,848
$114.22 P/Share
|
|
Aug 08
2024
|
Christopher S Holland Director |
SELL
Open market or private sale
|
Direct |
473
-44.83%
|
$113,047
$239.68 P/Share
|
|
Aug 08
2024
|
Christopher S Holland Director |
BUY
Grant, award, or other acquisition
|
Direct |
988
+48.36%
|
$236,132
$239.68 P/Share
|
|
Jun 05
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
3,652
-14.57%
|
$839,960
$230.0 P/Share
|
|
Jun 05
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
3,652
+11.96%
|
$266,596
$73.4 P/Share
|
|
Jun 05
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
4,932
-27.42%
|
$1,129,428
$229.63 P/Share
|
|
Jun 05
2024
|
Cary L Majors SVP and President, Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
4,932
+21.52%
|
$562,248
$114.22 P/Share
|
|
Jun 04
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,423
+7.38%
|
-
|
|
Jun 04
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
663
+8.79%
|
-
|
|
Jun 04
2024
|
Kenneth E Kohler SVP & GM, AST |
BUY
Grant, award, or other acquisition
|
Direct |
1,539
+30.65%
|
-
|
|
Jun 04
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
4,128
+11.02%
|
-
|
|
Jun 04
2024
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
2,379
+15.42%
|
-
|
|
Jun 04
2024
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,040
+15.49%
|
-
|
|
Jun 04
2024
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
918
+17.3%
|
-
|
|
Jun 04
2024
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,849
+18.58%
|
-
|
|
Jun 04
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+14.39%
|
-
|
|
Jun 04
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-2.39%
|
$242,364
$228.37 P/Share
|
|
Jun 03
2024
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-2.53%
|
$53,808
$228.37 P/Share
|
|
Jun 03
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-2.0%
|
$88,692
$228.37 P/Share
|
|
Jun 03
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,377
-1.93%
|
$541,956
$228.37 P/Share
|
|
Jun 03
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-0.81%
|
$164,844
$228.37 P/Share
|
|
Jun 03
2024
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
694
-6.1%
|
$158,232
$228.37 P/Share
|
|
Jun 03
2024
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-1.73%
|
$42,636
$228.37 P/Share
|
|
Jun 03
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,160
-1.28%
|
$264,480
$228.37 P/Share
|
|
Jun 03
2024
|
Kenneth E Kohler SVP & GM, AST |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-2.51%
|
$35,112
$228.37 P/Share
|
|
Jun 03
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-1.21%
|
$68,172
$228.37 P/Share
|
|
May 31
2024
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.14%
|
$76,812
$222.88 P/Share
|
|
May 31
2024
|
Kenneth E Kohler SVP & GM, AST |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-5.07%
|
$24,864
$222.88 P/Share
|
|
May 31
2024
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-2.42%
|
$45,954
$222.88 P/Share
|
|
May 31
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-1.08%
|
$15,984
$222.88 P/Share
|
|
May 31
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-1.37%
|
$128,760
$222.88 P/Share
|
|
May 31
2024
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-1.92%
|
$27,528
$222.88 P/Share
|
|
May 31
2024
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-2.74%
|
$285,492
$222.88 P/Share
|
|
May 31
2024
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
102
-2.71%
|
$22,644
$222.88 P/Share
|
|
May 21
2024
|
Richard C Breeden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584
+12.34%
|
$233,784
$51.53 P/Share
|
|
May 16
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Open market or private sale
|
Direct |
1,154
-14.74%
|
$266,574
$231.64 P/Share
|
|
May 16
2024
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,154
+12.84%
|
$131,556
$114.22 P/Share
|
|
May 15
2024
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
32,000
-12.66%
|
$7,488,000
$234.98 P/Share
|